Primemd Inc.
PRMD
$0.00
$0.000.00%
OTC PK
| 12/31/2008 | 09/30/2008 | 06/30/2008 | 03/31/2008 | 12/31/2007 | |
|---|---|---|---|---|---|
| Revenue | -57.66% | 67.74% | 64.29% | 76.47% | 104.96% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -57.66% | 67.74% | 64.29% | 76.47% | 104.96% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -57.66% | 67.74% | 64.29% | 76.47% | 104.96% |
| SG&A Expenses | -46.74% | -51.24% | -32.29% | -75.43% | -3.56% |
| Depreciation & Amortization | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -45.84% | -50.61% | -31.65% | -74.75% | -3.50% |
| Operating Income | 32.58% | 83.30% | 68.48% | 91.70% | 39.45% |
| Income Before Tax | 15.86% | 66.60% | -1,818.18% | -105.58% | -3.00% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 15.86% | 66.60% | -1,818.18% | -105.58% | -3.00% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 15.86% | 66.60% | -1,818.18% | -105.58% | -3.00% |
| EBIT | 32.58% | 83.30% | 68.48% | 91.70% | 39.45% |
| EBITDA | 33.96% | 85.00% | 70.00% | 92.74% | 40.45% |
| EPS Basic | 15.84% | 66.47% | -1,625.00% | -105.56% | -4.12% |
| Normalized Basic EPS | 15.87% | 66.67% | 47.56% | -105.62% | -3.28% |
| EPS Diluted | 15.84% | 66.47% | -1,625.00% | -105.56% | -4.12% |
| Normalized Diluted EPS | 15.87% | 66.67% | 47.56% | -105.62% | -3.28% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |